167 related articles for article (PubMed ID: 24642873)
1. The thrombotic events in polycythemia vera patients may be related to increased oxidative stress.
Durmus A; Mentese A; Yilmaz M; Sumer A; Akalin I; Topal C; Alver A
Med Princ Pract; 2014; 23(3):253-8. PubMed ID: 24642873
[TBL] [Abstract][Full Text] [Related]
2. Increased oxidative stress in patients with essential thrombocythemia.
Durmus A; Mentese A; Yilmaz M; Sumer A; Akalin I; Topal C; Alver A
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2860-6. PubMed ID: 24254553
[TBL] [Abstract][Full Text] [Related]
3. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
[TBL] [Abstract][Full Text] [Related]
4. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
Alvarez-Larrán A; Pérez-Encinas M; Ferrer-Marín F; Hernández-Boluda JC; Ramírez MJ; Martínez-López J; Magro E; Cruz Y; Mata MI; Aragües P; Fox ML; Cuevas B; Montesdeoca S; Hernández-Rivas JA; García-Gutiérrez V; Gómez-Casares MT; Steegmann JL; Durán MA; Gómez M; Kerguelen A; Bárez A; García MC; Boqué C; Raya JM; Martínez C; Albors M; García F; Burgaleta C; Besses C;
Haematologica; 2017 Jan; 102(1):103-109. PubMed ID: 27686377
[TBL] [Abstract][Full Text] [Related]
5. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
Tefferi A; Barbui T
Am J Hematol; 2019 Jan; 94(1):133-143. PubMed ID: 30281843
[TBL] [Abstract][Full Text] [Related]
6. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
7. The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera.
Podoltsev NA; Zhu M; Zeidan AM; Wang R; Wang X; Davidoff AJ; Huntington SF; Giri S; Gore SD; Ma X
Blood Adv; 2018 Oct; 2(20):2681-2690. PubMed ID: 30333100
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.
Geyer H; Scherber R; Kosiorek H; Dueck AC; Kiladjian JJ; Xiao Z; Slot S; Zweegman S; Sackmann F; Fuentes AK; Hernández-Maraver D; Döhner K; Harrison CN; Radia D; Muxi P; Besses C; Cervantes F; Johansson PL; Andreasson B; Rambaldi A; Barbui T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Maldonado N; Barosi G; Ferrari ML; Gale RP; Birgegard G; Xu Z; Zhang Y; Sun X; Xu J; Zhang P; te Boekhorst PA; Commandeur S; Schouten H; Pahl HL; Griesshammer M; Stegelmann F; Lehmann T; Senyak Z; Vannucchi AM; Passamonti F; Samuelsson J; Mesa RA
J Clin Oncol; 2016 Jan; 34(2):151-9. PubMed ID: 26598745
[TBL] [Abstract][Full Text] [Related]
9. Acute coronary disease in essential thrombocythemia and polycythemia vera.
Rossi C; Randi ML; Zerbinati P; Rinaldi V; Girolami A
J Intern Med; 1998 Jul; 244(1):49-53. PubMed ID: 9698024
[TBL] [Abstract][Full Text] [Related]
10. Lipid peroxidation levels and total oxidant/antioxidant status in serum and saliva from patients with chronic and aggressive periodontitis. Oxidative stress index: a new biomarker for periodontal disease?
Baltacıoğlu E; Yuva P; Aydın G; Alver A; Kahraman C; Karabulut E; Akalın FA
J Periodontol; 2014 Oct; 85(10):1432-41. PubMed ID: 24635543
[TBL] [Abstract][Full Text] [Related]
11. Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera.
Murphy P; Ahmed N; Hassan HT
Leuk Res; 2002 Nov; 26(11):1007-1010. PubMed ID: 12363469
[TBL] [Abstract][Full Text] [Related]
12. Treatment related changes in antifibrinolytic activity in patients with polycythemia vera.
Sonmez M; Saglam F; Karahan SC; Erkut N; Mentese A; Sonmez B; Ucar F; Topbas M; Ovali E
Hematology; 2010 Dec; 15(6):391-6. PubMed ID: 21114901
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic options for essential thrombocythemia and polycythemia vera.
Solberg LA
Semin Oncol; 2002 Jun; 29(3 Suppl 10):10-5. PubMed ID: 12096352
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic complications of polycythemia vera.
Varma S; Sharma A; Malhotra P; Kumari S; Jain S; Varma N
Hematology; 2008 Dec; 13(6):319-23. PubMed ID: 19055858
[TBL] [Abstract][Full Text] [Related]
15. Polycythemia vera--a case report and discussion on pathogenic mechanisms of increased thrombosis.
Gumina RJ; Foley DA; Tefferi A; Rooke TW; Shields RC
Angiology; 2002; 53(5):587-91. PubMed ID: 12365868
[TBL] [Abstract][Full Text] [Related]
16. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia.
Ann Intern Med; 1995 Nov; 123(9):656-64. PubMed ID: 7574220
[TBL] [Abstract][Full Text] [Related]
17. [Recent advances in polycythemia vera treatment].
Edahiro Y
Rinsho Ketsueki; 2020; 61(9):1187-1194. PubMed ID: 33162515
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and therapy of polycythemia vera.
Lengfelder E; Merx K; Hehlmann R
Semin Thromb Hemost; 2006 Apr; 32(3):267-75. PubMed ID: 16673281
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome in a cohort of young patients with polycythemia vera.
Ruggeri M; Finotto S; Fortuna S; Rodeghiero F
Intern Emerg Med; 2010 Oct; 5(5):411-3. PubMed ID: 20607450
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of arterial compliance in polycythemia vera patients: short and long-term influence of phlebotomy.
Nemets A; Isakov I; Huerta M; Barshai Y; Oren S; Lugassy G
Isr Med Assoc J; 2006 Dec; 8(12):845-7. PubMed ID: 17214101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]